PSMB2 and Alzheimer disease: Previous platelet proteomic studies have also demonstrated dysregulation of proteosome constituents [i.e., downregulation of PSMD6, PSMC6, PSMB1, PSMB2 (Donovan et al., 2013)] and ubiquitin mediated proteolysis in AD platelets (Yu et al., 2021).